Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Ww International Inc.

Start price
Target price
Perf. (%)
€1.53
16.04.24
-
16.04.25
-53.55%
11:01

Growths slower than the competition
Probably not worthwhile Investment
Little innovation
Little Investments for future growth
Lokrim 
16.04.24 20%
sell
Itaconix Plc

Start price
Target price
Perf. (%)
€1.42
16.04.24
-
16.04.25
24.65%
08.08.24

Growths slower than the competition
Lokrim 
16.04.24 20%
sell
Mediaco Holding Inc.

Start price
Target price
Perf. (%)
€2.26
16.04.24
-
16.04.25
57.52%
08.08.24

High valuation
Lokrim 
16.04.24 20%
sell
Equillium Inc.

Start price
Target price
Perf. (%)
€1.57
16.04.24
-
04.04.25
-59.04%
06.08.24

WatchMen 
16.04.24 50%
sell
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.24
16.04.24
-
16.04.25
14.52%
17.04.24

WatchMen 
16.04.24 50%
buy
Anebulo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.74
16.04.24
-
16.04.25
-34.31%
07.08.24

WatchMen 
16.04.24 50%
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.22
15.04.24
-
15.04.25
7.38%
28.04.24

Bankster 
15.04.24 50%
buy
Equinox Gold Corp.

Start price
Target price
Perf. (%)
€5.50
15.04.24
€6.00
15.04.25
-23.61%
15:01

montechristo681 
15.04.24 50%
sell
Xortx Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.06
15.04.24
-
09.03.25
-49.51%
10:00

WatchMen 
15.04.24 50%
buy
Pulsar Helium Inc.

Start price
Target price
Perf. (%)
€0.79
15.04.24
€3.00
15.03.25
-22.93%
08.08.24

WatchMen 
15.04.24 50%
sell
Globe Life Inc.

Start price
Target price
Perf. (%)
€53.00
15.04.24
-
12.04.25
13.21%
17.04.24

WatchMen 
15.04.24 50%
sell
Informatica Inc.

Start price
Target price
Perf. (%)
€33.86
15.04.24
-
15.04.25
-37.59%
05.08.24

WatchMen 
15.04.24 50%
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.48
15.04.24
-
15.04.25
0.20%
14:24

WatchMen 
15.04.24 50%
sell
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.45
15.04.24
€3.00
22.03.25
12.18%
17.04.24

WatchMen 
15.04.24 50%
sell
Cytek Biosciences Inc.

Start price
Target price
Perf. (%)
€5.60
15.04.24
-
15.04.25
-17.14%
08.08.24

WatchMen 
15.04.24 50%
sell
Ondas Holdings Inc.

Start price
Target price
Perf. (%)
€0.90
15.04.24
-
15.04.25
-10.61%
08.08.24

WatchMen 
15.04.24 50%
sell
Monopar Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.71
15.04.24
-
15.04.25
-12.77%
21.07.24

WatchMen 
15.04.24 50%
sell
Immuron

Start price
Target price
Perf. (%)
€2.28
15.04.24
-
15.04.25
-9.65%
08.08.24

WatchMen 
15.04.24 50%
sell
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€4.72
15.04.24
-
16.03.25
20.18%
07.08.24

WatchMen 
15.04.24 50%
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.50
15.04.24
-
15.04.25
-12.67%
27.04.24

me8 
15.04.24 0%
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.48
15.04.24
€35.00
31.12.25
-3.50%
22.06.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
buy
Addex Therapeutics Sa

Start price
Target price
Perf. (%)
€22.40
15.04.24
€35.00
29.03.26
-69.87%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 70%
buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€0.79
15.04.24
€2.00
15.04.25
41.40%
10:36

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
kostojunior 
15.04.24 80%
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.54
15.04.24
-
15.04.25
-13.13%
27.04.24

Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
kostojunior 
15.04.24 60%
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.35
15.04.24
€33.00
15.04.25
6.41%
27.04.24

positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
kostojunior 
15.04.24 80%